221880

Sigma-Aldrich

Zirconium(IV) chloride

greener alternative

≥99.5% trace metals basis

Synonym(s):
Zirconium tetrachloride, Tetrachlorozirconium
Linear Formula:
ZrCl4
CAS Number:
Molecular Weight:
233.04
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.23
Pricing and availability is not currently available.

Quality Level

vapor pressure

1 mmHg ( 190 °C)

assay

≥99.5% trace metals basis

form

powder

reaction suitability

reagent type: catalyst
core: zirconium

greener alternative product characteristics

Catalysis
Learn more about the Principles of Green Chemistry.

transition temp

sublimation point 331 °C

density

2.8 g/mL at 25 °C (lit.)

Featured Industry

Battery Manufacturing

SMILES string

ClZr(Cl)(Cl)Cl

InChI

1S/4ClH.Zr/h4*1H;/q;;;;+4/p-4

InChI key

DUNKXUFBGCUVQW-UHFFFAOYSA-J

Looking for similar products? Visit Product Comparison Guide

General description

We are committed to bringing you Greener Alternative Products, which adhere to one or more of The 12 Principles of Greener Chemistry. This product has been enhanced for catalytic efficiency. Click here for more information.

Application

Used to promote greener amidations of carboxylic acids and amines in catalytic amounts. This technology avoids the requirement of preactivation of the carboxylic acid or use of coupling reagents.

Direct amide formation from unactivated carboxylic acids and amines

Packaging

5, 100, 500 g in glass bottle

Pictograms

Corrosion

Signal Word

Danger

Hazard Statements

Supp Hazards

EUH014 - EUH071

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

Hazard Codes

C

Risk Statement

14-35

Safety Statement

26-36/37/39-45

RIDADR

UN 2503 8 / PGIII

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificate of Analysis
Certificate of Origin
Xiaoyin Xiao et al.
Langmuir : the ACS journal of surfaces and colloids, 27(15), 9484-9489 (2011-06-28)
We used positively charged lipids to prepare lipid bilayer assemblies (LBAs) upon which we assembled negatively charged gold nanoparticles (AuNPs). Treatment of the assembly with zirconium chloride resulted in the formation of nanorings of the diameters inversely related to the...
Surendra Singh et al.
The Journal of organic chemistry, 74(15), 5758-5761 (2009-07-04)
The ZrCl4-catalyzed deprotection of 1,3-dioxane/dioxalane and the simultaneous formation of 6-methoxy-substituted tetrahydropyrans proceeded under microwave irradiation in good yield. This synthetic methodology was used for the asymmetric synthesis of (+)-exo- and (+)-endo-brevicomin in 55% overall yield over 4 steps.
Lyudmila V Parfenova et al.
Molecules (Basel, Switzerland), 25(9) (2020-05-14)
Being valuable precursors in the production of adhesives, lubricants, and other high-performance synthetic compounds, alkene dimers and oligomers can be obtained using homogeneous zirconocene catalytic systems. Further advances in such systems require precise control of their activity and chemoselectivity, increasing...
Direct amide coupling of non-activated carboxylic acids and amines catalysed by zirconium(IV) chloride.
Helena Lundberg et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 18(13), 3822-3826 (2012-03-01)
Fouad Albaaj et al.
Drugs, 63(6), 577-596 (2003-03-27)
Hyperphosphataemia is prevalent among chronic renal failure and dialysis patients. It is known to stimulate parathyroid hormone and suppress vitamin D3 production, thereby inducing hyperparathyroid bone disease. In addition, it may independently contribute to cardiac causes of death through increased...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.